Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
|||
Line 83: | Line 83: | ||
| 2022.12.15 | | 2022.12.15 | ||
| [[Media:QIBA DWI-MR Clinical Feasibility Resolutions.pdf| Clinically Feasible Resolutions 2022-12-15]] | | [[Media:QIBA DWI-MR Clinical Feasibility Resolutions.pdf| Clinically Feasible Resolutions 2022-12-15]] | ||
+ | |- | ||
+ | |MR MRI-Based Proton Density Fat Fraction (PDFF) of the Liver | ||
+ | |Public Comment | ||
+ | |2023.09.08 | ||
+ | | | ||
|- | |- | ||
| colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles''' | | colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles''' |
Revision as of 23:31, 14 November 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.